QUEST DIAGNOSTICS INC

DGXSEC EDGAR

Services-Medical Laboratories(DE)CIK: 1022079

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$9.3B	$9.9B	$10.8B	$9.4B	$7.7B
Cost of Revenue	$6.2B	$6.5B	$6.6B	$5.8B	$5.0B
Gross Profit	—	—	—	—	—
Selling, General and Administrative Expense	$1.6B	$1.9B	$1.7B	$1.6B	$1.5B
Operating Income (Loss)	$1.3B	$1.4B	$2.4B	$2.0B	$1.2B
Interest Expense	—	—	$152.0M	$166.0M	$180.0M
Nonoperating Income (Expense)	-$132.0M	-$193.0M	$218.0M	-$87.0M	-$155.0M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$16.2B	$14.0B	$12.8B	$13.6B	$14.0B
Assets, Current	$2.4B	$2.4B	$1.9B	$2.7B	$3.1B
Cash and Cash Equivalents, at Carrying Value	$549.0M	$686.0M	$315.0M	$872.0M	$1.2B
Accounts Receivable, after Allowance for Credit Loss, Current	$1.3B	$1.2B	$1.2B	$1.4B	$1.5B
Inventory, Net	$188.0M	$190.0M	$192.0M	$208.0M	$223.0M
Liabilities, Current	$2.2B	$1.8B	$1.6B	$1.8B	$1.8B
Long-term Debt	$6.2B	$4.7B	$4.0B	$4.0B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$1.3B	$1.7B	$2.2B	$2.0B	$1.2B
Net Cash Provided by (Used in) Investing Activities	-$1.1B	-$543.0M	$21.0M	-$772.0M	-$411.0M
Net Cash Provided by (Used in) Financing Activities	$160.0M	-$1.7B	-$2.5B	-$1.3B	$225.0M
Payments to Acquire Property, Plant, and Equipment	$408.0M	$404.0M	$403.0M	$418.0M	$400.0M
Payments of Ordinary Dividends, Common Stock	$314.0M	$305.0M	$309.0M	$297.0M	$286.0M
Payments for Repurchase of Common Stock	$275.0M	$1.4B	$2.2B	$325.0M	$353.0M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)